Article
Zoliflodacin and gepotidacin cross-resistance in <i>Neisseria gonorrhoeae</i>
2025-11-25
Abstract excerpt
Resistance to zoliflodacin, a first-in-class antibiotic for gonorrhea treatment, can occur through gyrB D429N , but this mutation’s impact on fitness and resistance to other topoisomerase targeting drugs, including gepotidacin, have been unclear. Here, we show that gyrB D429N confers cross-resistance to gepotidacin in some clinical isolates and that its fitness effect varies with strain back-ground. These findin...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a8747fad-2117-529a-a139-c21c83fc7011
- DOI
- 10.1101/2025.11.25.690462
